SCA
PBH icon

Snowden Capital Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Snowden Capital Advisors’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-201
Closed -$12K – 1762
2021
Q4 		$12K Buy
+201
New +$11.9K ﹤0.01% 1475

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Snowden Capital Advisors's PBH Position: Q1 2022 in Review

Snowden Capital Advisors sold out of Prestige Consumer Healthcare (PBH) in Q1 2022, closing a stake of 201 shares — an estimated $12K sold.

Snowden Capital Advisors first reported a position in PBH in Q4 2021 and held it in 1 quarter. The position peaked at $12K in Q4 2021. 287 funds tracked by Wall St. Rank hold PBH as of Q1 2022.

  • Snowden Capital Advisors reported no remaining Prestige Consumer Healthcare position as of Q1 2022 after selling out during the quarter.
  • Snowden Capital Advisors sold 201 Prestige Consumer Healthcare shares in Q1 2022, an estimated $12K.
  • Snowden Capital Advisors first reported a position in Prestige Consumer Healthcare in Q4 2021 and held it in 1 quarter.
  • Snowden Capital Advisors's Prestige Consumer Healthcare position peaked at $12K in Q4 2021.
  • 287 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2022.

Based on Snowden Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.